08/12/2025
β
Ready Dossier Available
CALCIUM ACETATE TABLETS USP β 667 mg
A high-quality phosphate binder indicated for the management of hyperphosphatemia in patients with end-stage renal disease (ESRD).
πΉ Manufactured at a WHO-GMP compliant facility
πΉ Complete CTD/ACTD dossier available for registration
πΉ Suitable for regulated & semi-regulated markets
π© Contact for Dossier & Business Enquiries:
βοΈ export@westcoastin.com
π +91-99090 07949
π Partner with West-Coast Pharmaceutical Works Ltd. for reliable manufacturing and global regulatory support.